
Zymergen Investor Relations Material
Latest events

Status Update
Zymergen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Zymergen Inc
Access all reports
Zymergen Inc. designs, develops, and commercializes microbes, molecules, and materials for research in the life sciences. It offers a solution that automates biology experiments; a suite of software tools for automation of plants and facilities; hardware components comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; automation control software; and integrated automation systems with parts and services. The company also provides reagent bottles and automated dispensing systems, as well as small molecule screening and process development platform comprising single cell engineered microorganisms with tool kits for analysis. In addition, it offers consulting and advisory services comprising process design to manufacturing services using its solutions for process development, strain engineering, microbial characterization, culture media development, fermentor vessel design and validation services.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ZY
Country
🇺🇸 United States